- Home
- WFCF vs XGN Comparison
WFCF vs XGN Comparison
Compare WFCF & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFCF
- XGN
- Stock Information
- Founded
- WFCF 1996
- XGN 2002
- Country
- WFCF United States
- XGN United States
- Employees
- WFCF N/A
- XGN N/A
- Industry
- WFCF Computer Software: Prepackaged Software
- XGN Medical Specialities
- Sector
- WFCF Technology
- XGN Health Care
- Exchange
- WFCF Nasdaq
- XGN Nasdaq
- Market Cap
- WFCF 63.9M
- XGN 72.3M
- IPO Year
- WFCF 2011
- XGN 2019
- Fundamental
- Price
- WFCF $13.00
- XGN $5.65
- Analyst Decision
- WFCF
- XGN Buy
- Analyst Count
- WFCF 0
- XGN 1
- Target Price
- WFCF N/A
- XGN $7.00
- AVG Volume (30 Days)
- WFCF 5.5K
- XGN 189.6K
- Earning Date
- WFCF 11-12-2024
- XGN 11-12-2024
- Dividend Yield
- WFCF N/A
- XGN N/A
- EPS Growth
- WFCF 13.22
- XGN N/A
- EPS
- WFCF 0.36
- XGN N/A
- Revenue
- WFCF $25,815,000.00
- XGN $55,751,000.00
- Revenue This Year
- WFCF N/A
- XGN $6.74
- Revenue Next Year
- WFCF N/A
- XGN $17.32
- P/E Ratio
- WFCF $34.51
- XGN N/A
- Revenue Growth
- WFCF 5.38
- XGN 8.00
- 52 Week Low
- WFCF $9.76
- XGN $1.30
- 52 Week High
- WFCF $13.95
- XGN $6.22
- Technical
- Relative Strength Index (RSI)
- WFCF 60.46
- XGN 74.82
- Support Level
- WFCF $11.11
- XGN $5.60
- Resistance Level
- WFCF $12.68
- XGN $6.22
- Average True Range (ATR)
- WFCF 0.77
- XGN 0.48
- MACD
- WFCF -0.02
- XGN 0.13
- Stochastic Oscillator
- WFCF 65.53
- XGN 88.00
About WFCF Where Food Comes From Inc.
Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including IMI Global, International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.